The European Federation for Medicinal Chemistry (EFMC), the Medicinal Chemistry Section of the Austrian Chemical Society (G脰CH) and ChemBridge Corporation will be jointly organising the 7th edition of the EFMC International Symposium on Advances in Synthetic and Medicinal Chemistry (EFMC-ASMC鈥�17). This event is planned in the series which started in Moscow in 2004 (ASCMC'04 and ASMC'13), followed by St. Peterburg (ASMC'07 and ASMC'11), Kiev (ASMC'09) and the latest one in Rehovot, Israel (ASMC'15).
This symposium will bring together chemists from industry, academia and start-up companies from around the world and is focused on the most recent advances in new synthetic methodologies, total synthesis, fluorination approaches, bioisosteres and building blocks, chemical biology, medicinal chemistry, drug discovery and development leading to new or improved methods for the synthesis of pharmaceuticals.
Beyond key lectures in synthetic and fluorination chemistry, as well as recent case studies in medicinal chemistry and drug discovery, the symposium aims at bridging the range from 鈥榮mall molecules鈥� to 鈥榣arge molecules鈥� including carbohydrates, natural products, novel protein scaffolds and genes; it is expected to attract experts in synthetic chemistry, medicinal chemistry, total synthesis, catalysis, drug discovery, molecular imaging, and chemical development.
The general concept of the meeting, with talks equally selected from industry and academia, will include an opening lecture, 26 invited lectures, 10 short communications selected from submitted abstracts and a large poster session and commercial exhibition. The organisers are very happy to announce that the symposium will be chaired by:
This symposium will bring together chemists from industry, academia and start-up companies from around the world and is focused on the most recent advances in new synthetic methodologies, total synthesis, fluorination approaches, bioisosteres and building blocks, chemical biology, medicinal chemistry, drug discovery and development leading to new or improved methods for the synthesis of pharmaceuticals.
Beyond key lectures in synthetic and fluorination chemistry, as well as recent case studies in medicinal chemistry and drug discovery, the symposium aims at bridging the range from 鈥榮mall molecules鈥� to 鈥榣arge molecules鈥� including carbohydrates, natural products, novel protein scaffolds and genes; it is expected to attract experts in synthetic chemistry, medicinal chemistry, total synthesis, catalysis, drug discovery, molecular imaging, and chemical development.
The general concept of the meeting, with talks equally selected from industry and academia, will include an opening lecture, 26 invited lectures, 10 short communications selected from submitted abstracts and a large poster session and commercial exhibition. The organisers are very happy to announce that the symposium will be chaired by:
- Karin BRINER (Novartis, United States)
- Erick M. CARREIRA (ETH Zurich, Switzerland)
